英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Zufall查看　Zufall　在百度字典中的解释百度英翻中〔查看〕
Zufall查看　Zufall　在Google字典中的解释Google英翻中〔查看〕
Zufall查看　Zufall　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Legal - ESMO
    Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits
  • EN | Non-Small-Cell Lung Cancer: Guide for Patients
    8 2 million cancer-related deaths, the majority of which occurred in low- and middle-income countries; Recognizing that cancer is a leading cause of morbidity globally and a growing public health concern, with the annual number of new cancer cases projected to increase from 14 1 million in 2012 to 21 6 million by 2030;
  • Afatinib LUX - Lung 3
    metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s) - Del19 L858R pre-planned subgroup analysis Experimental Arm: Afatinib Control Arm: Cisplatin + pemetrexed Improved QoL Overall Survival Disease-Free Survival Pathological Complete Response Overall Survival Progression-Free Survival
  • Archive - ESMO
    Nivolumab is the first PD-1 inhibitor to statistically significantly improve overall survival (OS) vs docetaxel in previously treated patients with advanced non-squamous cell non-small cell lung cancer (NSCLC) It significantly improved overall response rate (ORR) as well
  • Melanoma: Latest trial results for targeted therapies - ESMO
    with targeted agents in non-small-cell lung cancer (NSCLC) subtypes One reported that the BRAF inhibitor, dabrafenib, which is used to treat BRAF V600E-mutated melanoma, produced responses in nearly one-third of patients with NSCLC harbouring the same mutation (LBA38_PR) The other study (LBA39_PR) indicated that a combination of the
  • Find out what’s in store for you at RB1 mutation status does not Asian . . .
    of advanced lung cancer Today, Martin Reck (Lung Clinic Grosshansdorf, Germany) will present health status results from the CheckMate 057 trial comparing the anti-PD-1 antibody, nivolumab, with docetaxel in patients with previously treated advanced non-squamous non-small-cell lung cancer (14 30 – 16 00, Hall 406, Abstract 442O)
  • The Evolving Power of Immunotherapy
    %PDF-1 7 %âãÏÓ 132 0 obj > endobj xref 132 90 0000000016 00000 n 0000002647 00000 n 0000002803 00000 n 0000003439 00000 n 0000003488 00000 n 0000003602 00000 n 0000005664 00000 n 0000007586 00000 n 0000008061 00000 n 0000008793 00000 n 0000009330 00000 n 0000009761 00000 n 0000010177 00000 n 0000012284 00000 n 0000014546 00000 n 0000016895 00000 n 0000019000 00000 n 0000020950 00000 n





中文字典-英文字典  2005-2009